1104. Risk Factors and Outcomes of Refractory and/or Resistant Cytomegalovirus (CMV) Infection after Allogeneic Hematopoietic Stem Cell Transplantation

BACKGROUND: The epidemiology of CMV end-organ disease (EOD) after Hematopoietic Cell Transplant (HCT) in the era of preemptive therapy (PET) is defined. In contrast, less data exists on refractory and/or resistant (R/R) CMV. We report on 1) the incidence; 2) risk factors and outcomes of R/R CMV by 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Karantoni, Eleni, Su, Yiqi, Stern, Anat, Zavras, Phaedon D, Giralt, Sergio, Perales, Miguel-Angel, Papanicolaou, Genovefa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777056/
http://dx.doi.org/10.1093/ofid/ofaa439.1290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777056/
http://dx.doi.org/10.1093/ofid/ofaa439.1290

Ejemplares similares